Brief: PharmaSGP Holding 9M EBITDA EUR 24.8 Million
14/11/2023 06:31
Nov 14 (Reuters) - PharmaSGP Holding 9-month revenue EUR 75.7 million. * 9-month EBITDA EUR 24.8 million * 9-month adjusted EBITDA EUR 24.7 million * 9-month adjusted EBITDA margin 32.7% * Outlook FY adjusted EBITDA EUR 30-34 million * 9-month EBITDA margin 32.7% * Outlook FY revenue EUR 95-100 million
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million